NCT03057041View on ClinicalTrials.gov

Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

March 23, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Pain Uterus
Interventions
DRUG

Fentanyl

100 mcg of intranasal fentanyl, 50 mcg/ mL in each nostril via mucosal atomizer 15 minutes prior to procedure start

DRUG

placebo

1 mL of sterile saline in each nostril via mucosal atomizer 15 minutes prior to procedure start

Trial Locations (2)

96826

Women's Options Center, Honolulu

97212

Planned Parenthood Columbia Willamette, Portland

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

University of Hawaii

OTHER

NCT03057041 - Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration | Biotech Hunter | Biotech Hunter